Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Milrinone mechanism of action?Soliqua 100 33 clinical trials?Valtoco nasal spray price?Calcium acetate for sale?Alvogen levothyroxine?
See the DrugPatentWatch profile for Fluticasone
Fluticasone–salmeterol 232/14 (often written as 232 mcg of fluticasone/14 mcg of salmeterol) is commonly marketed as Wixela Inhub in the U.S. [1].
Products using the same drug combination may come in different dose strengths (for example, 100/50, 250/50, 232/14), and brands can differ by strength and country. That’s why the exact “232/14” number matters when identifying the brand [1].
In many cases, fluticasone–salmeterol products are compared to Advair (which uses the same medication pairing but is typically labeled with different strengths). If you are looking specifically for “232/14,” that strength corresponds to a specific labeled product/packaging—so check the label for the exact numbers [1].
Check the box label or the back of the inhaler packaging for the strength written as “232/14” (and confirm the brand name shown there). Pharmacy databases and manufacturer labeling typically tie that exact strength to the marketed product [1]. Sources [1] https://www.drugpatentwatch.com/
Other Questions About Fluticasone :